ASCO Daily News

134 Folgen

1. ASCO23: Novel Approaches in RCC, mUC, and Prostate Cancer

   Vom: 25.5.2023
2. ASCO23: CodeBreak-101, NAPOLI-3, and Other Advances in GI Cancers

   Vom: 25.5.2023
3. ASCO23: Novel Therapies in Lung Cancer 

   Vom: 25.5.2023
4. ASCO23: PALMIRA, LEONARDA-1, and Other Advances in Breast Cancer

   Vom: 25.5.2023
5. ASCO23: Key Abstracts from Precision Oncology to Cancer Disparities

   Vom: 25.5.2023
6. S2302 Pragmatica-Lung and the Promise of Streamlined Clinical Trials

   Vom: 13.4.2023
7. Advances in Neoadjuvant IO in MSI-H/dMMR Colorectal Cancer

   Vom: 16.3.2023
8. Key Abstracts in Prostate, Bladder, and Kidney Cancers at GU23

   Vom: 2.3.2023
9. ARASENS, TRITON3, and Other Key Advances at GU23

   Vom: 13.2.2023
10. SWOG 1815, PARADIGM, and Other Advances at GI23

    Vom: 2.2.2023
11. Fertility Concerns, Family Planning, and Career Decisions Among Female Oncologists

    Vom: 5.1.2023
12. What Challenges Will Oncologists Face in 2023?

    Vom: 8.12.2022
13. Developing the Next Generation of Prostate Cancer Researchers

    Vom: 15.11.2022
14. Novel Therapies Targeting KRAS in Lung Cancer & RAS-Altered Tumors

    Vom: 3.11.2022
15. Advancing Equity and Quality Cancer Care at #ASCOQLTY22

    Vom: 14.10.2022
16. The Impact of Hurricane Ian on Cancer Care

    Vom: 12.10.2022
17. How Primary Tumor Sidedness Impacts Treatment and Other Advances in Colorectal Cancer

    Vom: 15.9.2022
18. Update from Poland: Cancer Care for Ukrainian Refugees

    Vom: 11.8.2022
19. A Novel Approach to Address Financial Toxicity

    Vom: 28.7.2022
20. Hidden Gems From ASCO22: Abstracts on EDI, Health Care Economics, and More

    Vom: 14.7.2022